vs

Side-by-side financial comparison of Madison Square Garden Sports Corp. (MSGS) and Privia Health Group, Inc. (PRVA). Click either name above to swap in a different company.

Privia Health Group, Inc. is the larger business by last-quarter revenue ($541.2M vs $403.4M, roughly 1.3× Madison Square Garden Sports Corp.). Madison Square Garden Sports Corp. runs the higher net margin — 2.0% vs 1.7%, a 0.4% gap on every dollar of revenue. On growth, Privia Health Group, Inc. posted the faster year-over-year revenue change (17.4% vs 12.8%). Over the past eight quarters, Privia Health Group, Inc.'s revenue compounded faster (14.2% CAGR vs -3.1%).

Madison Square Garden Sports Corp. is an American sports holding company based in New York City.

Privia Health Group, Inc. is a U.S.-headquartered healthcare technology and services firm supporting independent practices, health systems, and payers delivering value-based care. It offers population health tools, patient engagement platforms, care coordination support, and workflow solutions to boost patient outcomes and cut operational costs for U.S. healthcare stakeholders.

MSGS vs PRVA — Head-to-Head

Bigger by revenue
PRVA
PRVA
1.3× larger
PRVA
$541.2M
$403.4M
MSGS
Growing faster (revenue YoY)
PRVA
PRVA
+4.7% gap
PRVA
17.4%
12.8%
MSGS
Higher net margin
MSGS
MSGS
0.4% more per $
MSGS
2.0%
1.7%
PRVA
Faster 2-yr revenue CAGR
PRVA
PRVA
Annualised
PRVA
14.2%
-3.1%
MSGS

Income Statement — Q2 FY2026 vs Q4 FY2025

Metric
MSGS
MSGS
PRVA
PRVA
Revenue
$403.4M
$541.2M
Net Profit
$8.2M
$9.2M
Gross Margin
Operating Margin
5.5%
2.1%
Net Margin
2.0%
1.7%
Revenue YoY
12.8%
17.4%
Net Profit YoY
641.9%
108.0%
EPS (diluted)
$0.34
$0.08

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
MSGS
MSGS
PRVA
PRVA
Q4 25
$403.4M
$541.2M
Q3 25
$39.5M
$580.4M
Q2 25
$204.0M
$521.2M
Q1 25
$424.2M
$480.1M
Q4 24
$357.8M
$460.9M
Q3 24
$53.3M
$437.9M
Q2 24
$227.3M
$422.3M
Q1 24
$430.0M
$415.2M
Net Profit
MSGS
MSGS
PRVA
PRVA
Q4 25
$8.2M
$9.2M
Q3 25
$-8.8M
$6.9M
Q2 25
$-1.8M
$2.7M
Q1 25
$-14.2M
$4.2M
Q4 24
$1.1M
$4.4M
Q3 24
$-7.5M
$3.5M
Q2 24
$25.5M
$3.5M
Q1 24
$37.9M
$3.0M
Operating Margin
MSGS
MSGS
PRVA
PRVA
Q4 25
5.5%
2.1%
Q3 25
-69.5%
2.5%
Q2 25
-11.1%
0.6%
Q1 25
7.6%
1.1%
Q4 24
3.7%
1.1%
Q3 24
-15.5%
1.3%
Q2 24
23.0%
1.2%
Q1 24
18.5%
0.2%
Net Margin
MSGS
MSGS
PRVA
PRVA
Q4 25
2.0%
1.7%
Q3 25
-22.3%
1.2%
Q2 25
-0.9%
0.5%
Q1 25
-3.4%
0.9%
Q4 24
0.3%
1.0%
Q3 24
-14.1%
0.8%
Q2 24
11.2%
0.8%
Q1 24
8.8%
0.7%
EPS (diluted)
MSGS
MSGS
PRVA
PRVA
Q4 25
$0.34
$0.08
Q3 25
$-0.37
$0.05
Q2 25
$-0.08
$0.02
Q1 25
$-0.59
$0.03
Q4 24
$0.05
$0.03
Q3 24
$-0.31
$0.03
Q2 24
$1.07
$0.03
Q1 24
$1.57
$0.02

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
MSGS
MSGS
PRVA
PRVA
Cash + ST InvestmentsLiquidity on hand
$81.3M
$479.7M
Total DebtLower is stronger
Stockholders' EquityBook value
$-282.1M
$737.2M
Total Assets
$1.5B
$1.4B
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
MSGS
MSGS
PRVA
PRVA
Q4 25
$81.3M
$479.7M
Q3 25
$48.6M
$441.4M
Q2 25
$144.6M
$390.1M
Q1 25
$96.5M
$469.3M
Q4 24
$107.8M
$491.1M
Q3 24
$52.3M
$422.0M
Q2 24
$89.1M
$387.4M
Q1 24
$40.0M
$351.1M
Stockholders' Equity
MSGS
MSGS
PRVA
PRVA
Q4 25
$-282.1M
$737.2M
Q3 25
$-294.2M
$709.1M
Q2 25
$-281.4M
$682.9M
Q1 25
$-283.4M
$659.4M
Q4 24
$-273.1M
$635.2M
Q3 24
$-277.5M
$614.9M
Q2 24
$-266.3M
$595.4M
Q1 24
$-294.0M
$576.8M
Total Assets
MSGS
MSGS
PRVA
PRVA
Q4 25
$1.5B
$1.4B
Q3 25
$1.5B
$1.4B
Q2 25
$1.5B
$1.3B
Q1 25
$1.5B
$1.2B
Q4 24
$1.4B
$1.1B
Q3 24
$1.4B
$1.1B
Q2 24
$1.3B
$1.1B
Q1 24
$1.4B
$1.0B

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
MSGS
MSGS
PRVA
PRVA
Operating Cash FlowLast quarter
$32.4M
$127.5M
Free Cash FlowOCF − Capex
$31.6M
FCF MarginFCF / Revenue
7.8%
Capex IntensityCapex / Revenue
0.2%
Cash ConversionOCF / Net Profit
3.94×
13.93×
TTM Free Cash FlowTrailing 4 quarters
$-480.0K

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
MSGS
MSGS
PRVA
PRVA
Q4 25
$32.4M
$127.5M
Q3 25
$-85.0M
$52.0M
Q2 25
$49.7M
$8.0M
Q1 25
$6.3M
$-24.1M
Q4 24
$61.8M
$74.8M
Q3 24
$-26.2M
$33.2M
Q2 24
$108.4M
$34.5M
Q1 24
$4.0M
$-33.1M
Free Cash Flow
MSGS
MSGS
PRVA
PRVA
Q4 25
$31.6M
Q3 25
$-85.3M
Q2 25
$49.4M
Q1 25
$3.9M
Q4 24
$61.2M
Q3 24
$-26.5M
Q2 24
$108.0M
Q1 24
$3.9M
FCF Margin
MSGS
MSGS
PRVA
PRVA
Q4 25
7.8%
Q3 25
-216.3%
Q2 25
24.2%
Q1 25
0.9%
Q4 24
17.1%
Q3 24
-49.7%
Q2 24
47.5%
Q1 24
0.9%
Capex Intensity
MSGS
MSGS
PRVA
PRVA
Q4 25
0.2%
Q3 25
0.9%
Q2 25
0.2%
Q1 25
0.6%
Q4 24
0.1%
Q3 24
0.7%
Q2 24
0.2%
Q1 24
0.0%
Cash Conversion
MSGS
MSGS
PRVA
PRVA
Q4 25
3.94×
13.93×
Q3 25
7.58×
Q2 25
2.97×
Q1 25
-5.70×
Q4 24
55.61×
17.00×
Q3 24
9.38×
Q2 24
4.25×
9.94×
Q1 24
0.11×
-11.10×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

MSGS
MSGS

Event Related$167.2M41%
Media Rights$122.3M30%
Sponsorship Signage And Suite Licenses$98.5M24%
League Distribution$15.4M4%

PRVA
PRVA

FFS Patient Care$364.4M67%
Capitated Revenue$71.4M13%
Shared Savings$46.9M9%
FFS Administrative Services$36.0M7%
Care Management Fee PMPM$20.0M4%
Other Revenue$2.5M0%

Related Comparisons